AEGIS, aegis, Aegis, AEGISITN, aegisitn, AEGIS-ITN, aegis-itn,drug discovery, drug development, structure based drug discovery, early stage drug discovery, fragment based drug discovery, PhD program, Doktorandenprogramm, rare disease, neglected disease, Malaria, Leishmania, Chagas disease, Trypanosomia, Tuberculosis, compounds, targets, AEGIS, aegis, Aegis, AEGISITN, aegisitn, AEGIS-ITN, aegis-itn,drug discovery, drug development, structure based drug discovery, early stage drug discovery, fragment based drug discovery, PhD program, Doktorandenprogramm, rare disease, neglected disease, Malaria, Leishmania, Chagas disease, Trypanosomia, Tuberculosis, compounds, targets,AEGIS (Accelerated Early staGe drig dIScovery) is an European Marie Sklodowska-Curie Innovative Network program. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on early stage drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on fragment based drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on structure based drug discovery / development. AEGIS is a doctoral education program. AEGIS is a PhD program. AEGIS bildet Doktoranden aus. AEGIS ist ein Forschungsprojekt auf dem Gebiet der strukturbasierten Wirkstoffforschung. AEGIS will develop active compounds against rare and neglected diseases. AEGIS will develop compounds for Malaria, Leishmania, Chagas disease, Trypanosomia and Tuberculosis.,AEGIS (Accelerated Early staGe drig dIScovery) is an European Marie Sklodowska-Curie Innovative Network program. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on early stage drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on fragment based drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on structure based drug discovery / development. AEGIS is a doctoral education program. AEGIS is a PhD program. AEGIS bildet Doktoranden aus. AEGIS ist ein Forschungsprojekt auf dem Gebiet der strukturbasierten Wirkstoffforschung. AEGIS will develop active compounds against rare and neglected diseases. AEGIS will develop compounds for Malaria, Leishmania, Chagas disease, Trypanosomia and Tuberculosis.AEGIS, aegis, Aegis, AEGISITN, aegisitn, AEGIS-ITN, aegis-itn,drug discovery, drug development, structure based drug discovery, early stage drug discovery, fragment based drug discovery, PhD program, Doktorandenprogramm, rare disease, neglected disease, Malaria, Leishmania, Chagas disease, Trypanosomia, Tuberculosis, compounds, targets, AEGIS, aegis, Aegis, AEGISITN, aegisitn, AEGIS-ITN, aegis-itn,drug discovery, drug development, structure based drug discovery, early stage drug discovery, fragment based drug discovery, PhD program, Doktorandenprogramm, rare disease, neglected disease, Malaria, Leishmania, Chagas disease, Trypanosomia, Tuberculosis, compounds, targets,AEGIS (Accelerated Early staGe drig dIScovery) is an European Marie Sklodowska-Curie Innovative Network program. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on early stage drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on fragment based drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on structure based drug discovery / development. AEGIS is a doctoral education program. AEGIS is a PhD program. AEGIS bildet Doktoranden aus. AEGIS ist ein Forschungsprojekt auf dem Gebiet der strukturbasierten Wirkstoffforschung. AEGIS will develop active compounds against rare and neglected diseases. AEGIS will develop compounds for Malaria, Leishmania, Chagas disease, Trypanosomia and Tuberculosis.,AEGIS (Accelerated Early staGe drig dIScovery) is an European Marie Sklodowska-Curie Innovative Network program. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on early stage drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on fragment based drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on structure based drug discovery / development. AEGIS is a doctoral education program. AEGIS is a PhD program. AEGIS bildet Doktoranden aus. AEGIS ist ein Forschungsprojekt auf dem Gebiet der strukturbasierten Wirkstoffforschung. AEGIS will develop active compounds against rare and neglected diseases. AEGIS will develop compounds for Malaria, Leishmania, Chagas disease, Trypanosomia and Tuberculosis.AEGIS, aegis, Aegis, AEGISITN, aegisitn, AEGIS-ITN, aegis-itn,drug discovery, drug development, structure based drug discovery, early stage drug discovery, fragment based drug discovery, PhD program, Doktorandenprogramm, rare disease, neglected disease, Malaria, Leishmania, Chagas disease, Trypanosomia, Tuberculosis, compounds, targets, AEGIS, aegis, Aegis, AEGISITN, aegisitn, AEGIS-ITN, aegis-itn,drug discovery, drug development, structure based drug discovery, early stage drug discovery, fragment based drug discovery, PhD program, Doktorandenprogramm, rare disease, neglected disease, Malaria, Leishmania, Chagas disease, Trypanosomia, Tuberculosis, compounds, targets,AEGIS (Accelerated Early staGe drig dIScovery) is an European Marie Sklodowska-Curie Innovative Network program. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on early stage drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on fragment based drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on structure based drug discovery / development. AEGIS is a doctoral education program. AEGIS is a PhD program. AEGIS bildet Doktoranden aus. AEGIS ist ein Forschungsprojekt auf dem Gebiet der strukturbasierten Wirkstoffforschung. AEGIS will develop active compounds against rare and neglected diseases. AEGIS will develop compounds for Malaria, Leishmania, Chagas disease, Trypanosomia and Tuberculosis.,AEGIS (Accelerated Early staGe drig dIScovery) is an European Marie Sklodowska-Curie Innovative Network program. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on early stage drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on fragment based drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on structure based drug discovery / development. AEGIS is a doctoral education program. AEGIS is a PhD program. AEGIS bildet Doktoranden aus. AEGIS ist ein Forschungsprojekt auf dem Gebiet der strukturbasierten Wirkstoffforschung. AEGIS will develop active compounds against rare and neglected diseases. AEGIS will develop compounds for Malaria, Leishmania, Chagas disease, Trypanosomia and Tuberculosis.AEGIS, aegis, Aegis, AEGISITN, aegisitn, AEGIS-ITN, aegis-itn,drug discovery, drug development, structure based drug discovery, early stage drug discovery, fragment based drug discovery, PhD program, Doktorandenprogramm, rare disease, neglected disease, Malaria, Leishmania, Chagas disease, Trypanosomia, Tuberculosis, compounds, targets, AEGIS, aegis, Aegis, AEGISITN, aegisitn, AEGIS-ITN, aegis-itn,drug discovery, drug development, structure based drug discovery, early stage drug discovery, fragment based drug discovery, PhD program, Doktorandenprogramm, rare disease, neglected disease, Malaria, Leishmania, Chagas disease, Trypanosomia, Tuberculosis, compounds, targets,AEGIS (Accelerated Early staGe drig dIScovery) is an European Marie Sklodowska-Curie Innovative Network program. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on early stage drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on fragment based drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on structure based drug discovery / development. AEGIS is a doctoral education program. AEGIS is a PhD program. AEGIS bildet Doktoranden aus. AEGIS ist ein Forschungsprojekt auf dem Gebiet der strukturbasierten Wirkstoffforschung. AEGIS will develop active compounds against rare and neglected diseases. AEGIS will develop compounds for Malaria, Leishmania, Chagas disease, Trypanosomia and Tuberculosis.,AEGIS (Accelerated Early staGe drig dIScovery) is an European Marie Sklodowska-Curie Innovative Network program. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on early stage drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on fragment based drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on structure based drug discovery / development. AEGIS is a doctoral education program. AEGIS is a PhD program. AEGIS bildet Doktoranden aus. AEGIS ist ein Forschungsprojekt auf dem Gebiet der strukturbasierten Wirkstoffforschung. AEGIS will develop active compounds against rare and neglected diseases. AEGIS will develop compounds for Malaria, Leishmania, Chagas disease, Trypanosomia and Tuberculosis.AEGIS, aegis, Aegis, AEGISITN, aegisitn, AEGIS-ITN, aegis-itn,drug discovery, drug development, structure based drug discovery, early stage drug discovery, fragment based drug discovery, PhD program, Doktorandenprogramm, rare disease, neglected disease, Malaria, Leishmania, Chagas disease, Trypanosomia, Tuberculosis, compounds, targets, AEGIS, aegis, Aegis, AEGISITN, aegisitn, AEGIS-ITN, aegis-itn,drug discovery, drug development, structure based drug discovery, early stage drug discovery, fragment based drug discovery, PhD program, Doktorandenprogramm, rare disease, neglected disease, Malaria, Leishmania, Chagas disease, Trypanosomia, Tuberculosis, compounds, targets,AEGIS (Accelerated Early staGe drig dIScovery) is an European Marie Sklodowska-Curie Innovative Network program. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on early stage drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on fragment based drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on structure based drug discovery / development. AEGIS is a doctoral education program. AEGIS is a PhD program. AEGIS bildet Doktoranden aus. AEGIS ist ein Forschungsprojekt auf dem Gebiet der strukturbasierten Wirkstoffforschung. AEGIS will develop active compounds against rare and neglected diseases. AEGIS will develop compounds for Malaria, Leishmania, Chagas disease, Trypanosomia and Tuberculosis.,AEGIS (Accelerated Early staGe drig dIScovery) is an European Marie Sklodowska-Curie Innovative Network program. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on early stage drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on fragment based drug discovery / development. AEGIS (Accelerated Early staGe drig dIScovery) is a scientific research project on structure based drug discovery / development. AEGIS is a doctoral education program. AEGIS is a PhD program. AEGIS bildet Doktoranden aus. AEGIS ist ein Forschungsprojekt auf dem Gebiet der strukturbasierten Wirkstoffforschung. AEGIS will develop active compounds against rare and neglected diseases. AEGIS will develop compounds for Malaria, Leishmania, Chagas disease, Trypanosomia and Tuberculosis.

Skip to main content
logo logoMarie-Curie

Marie Sklodowska-Curie actions

4th Workshop of the Helmholtz Association “Cross Programme Activity Structural Biology”, 20 - 21 Nov 2017

Dear colleagues,

 

The 4th Workshop of the Helmholtz Association “Cross Programme Activity Structural Biology” will be held on November 20th and 21st 2017 in Düsseldorf.

The workshop will be hosted by the Forschungszentrum Jülich and the Heinrich-Heine-Universität Düsseldorf and brings together researchers from various Helmholtz Centers and Research Fields (DESY, DKFZ, DZNE, FZJ, HMGU, HZB, HZI, KIT, MDC) of the Helmholtz Association and collaborating institutions (CSSB, EMBL, FMP, TUM, Uni Düsseldorf) to present and exchange current structural biology research in understanding structural mechanisms in biology and biomedicine.

The workshop also hosts the thematic working group “Structure-Based Drug Discovery” of the Helmholtz Portfolio Programme “Wirkstoffforschung”.

The meeting will cover current topics of integrated structural biology in the Helmholtz Association focusing on structure and dynamics of biological macromolecules and their complexes, featuring new technologies and infrastructures, structural cell biology and structure-based drug discovery.

Please register by e-mail to the organisation office and submit an abstract if you would like to contribute an oral talk or poster.

 

15 Oct, 2017.

Please just email your abstracts to the organisation office.


Venue
Haus der Universität
40212 Düsseldorf

How to get here by public transport and by car.

 

Accommodation

A limited number of rooms for external participants have been reserved at Hotel Favor (134,90 Euro/room-single use and 146,90 Euro/room-double use) and Hotel-Düsseldorf-Mitte (87,- Euro/room). Because of the limited availability of hotel rooms, we would like to ask all PhD students to book double rooms at Hotel Favor. Please contact the hotels directly and use the keyword CPA2017 to obtain the special rate at both hotels.